Related Experiment Videos

Nuclear translocation of the estrogen receptor in autonomous C3H mouse mammary tumors

Cancer Research
|June 1, 1978
PubMed

Insights

Estrogen receptors in C3H mouse mammary tumors bind estradiol and translocate to the nucleus. This indicates that defects in these initial steps do not cause estrogen independence in these tumors.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • C3H mouse mammary tumors exhibit estrogen independence, a phenomenon not fully understood.
  • Investigating the initial steps of estradiol action is crucial for understanding this independence.

Purpose of the Study:

  • To determine if defects in initial estradiol action steps, specifically estrogen receptor binding and nuclear translocation, contribute to estrogen independence in C3H mouse mammary tumors.

Main Methods:

  • Characterization of estrogen receptors in cytosol and nuclear extracts.
  • Assessment of estrogen receptor nuclear translocation using radioactive estradiol and specific precipitation assays (protamine sulfate, hydroxylapatite).
  • Comparison of results with dextran-coated charcoal assay limitations.

Main Results:

  • Estrogen receptors in C3H mammary tumors demonstrated high affinity, specificity, DNA binding, and appropriate sedimentation characteristics.
  • Specific assays confirmed estrogen receptor translocation into the nucleus, contradicting findings from the dextran-coated charcoal assay.
  • Estrogen receptor concentrations in cytosol and nuclear extracts were quantified.

Conclusions:

  • The estrogen independence of C3H mouse mammary tumors is not attributable to defects in initial estradiol action, including cytosol binding or nuclear translocation of estrogen receptors.
  • The study highlights the importance of using specific assays to accurately measure estrogen receptor nuclear translocation.

Related Concept Videos